Nabriva Therapeutics PLC (NBRVF)
Market Closed
11 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 00
0
0%
$
323 Market Cap
- P/E Ratio
- Div Yield
780 Volume
- Eps
$ 0
Previous Close Want to track NBRVF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nabriva Therapeutics PLC (NBRVF) Statistics
Valuation metrics
Market Cap 323
Enterprise value -7.19M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0
Price/Book (mrq) 0
Enterprise Value/Revenue -0.2
Enterprise Value/EBITDA 0.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 195
Average volume (90 days) 308
Price summary
52-Week low 0
52-Week high 0
Beta -
50-Day moving average 0
200-Day moving average 0
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 16 Sep 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.6%
Operating margin -1.56%
Operational effectiveness
Return on assets -1.8%
Return on equity -2.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -21.32
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.63
Total debt (mrq) -
Total Debt/Equity (mrq) 1.59
Current ratio (mrq) 1.13%
Book value per share (mrq) 1.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
